| (CAD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 39.84M | — |
| Operating expense | — | — |
| Net income | 758.12K | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, MDP.TO returned +80.1% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +77.7% |
| 1 year | +80.1% |
| 5 years | +24.0% |
| 10 years | +14.9% |
| All-time high | $7.90 (Mar 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in MDP.TO would be worth today ›No. Medexus Pharmaceuticals Inc. has not paid a dividend in the past 12 months.
Medexus Pharmaceuticals Inc. is part of the Healthcare sector.
Medexus Pharmaceuticals Inc. has a market cap of 162.47M CAD, based on the latest quote.
Medexus Pharmaceuticals Inc. is expected to report earnings around Nov 11, 2026. That date is an estimate and has not been confirmed by the company.
